Glenn Liu, MD
Enriched profileProfessor of Medicine and Medical Physics; Head, Genitourinary Oncology Section, Division of Hematology, Medical Oncology and Palliative Care · University of Wisconsin Carbone Cancer Center
Glenn Liu is Professor of Medicine and Medical Physics; Head, Genitourinary Oncology Section, Division of Hematology, Medical Oncology and Palliative Care at University of Wisconsin Carbone Cancer Center. OpenAlex indexes 232 publications with 14,269 citations (h-index 53); ClinicalTrials.gov lists 17 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Glenn Liu, MD, is Professor of Medicine and Medical Physics at University of Wisconsin Carbone Cancer Center / University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison. The public record shows 232 publications with 14,269 citations (h-index 53), centered on Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 6 companies, 3 NIH-funded awards (2011–2025).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Prostate Cancer Treatment and Research
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 125.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Using FAPI PET/MRI to Evaluate Prostate Cancer
Sponsor: University of Wisconsin, Madison
- PET/CT Characterization of Treatment Resistance
Sponsor: University of Wisconsin, Madison
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Sponsor: University of Washington
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2022–2024. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year20241 payment
- GENZYME CORPORATIONProgram year20231 payment
- PFIZER INC.Program year20233 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
55.7%Cytochrome P450 17A1 Inhibitor26%Abiraterone Acetate100%Part D≥18 patientsAndrogen Receptor Inhibitor13%Xtandi59%Bicalutamide41%Part D<11 patientsMetabolism & gastrointestinal
37.4%Corticosteroid37.4%Prednisone100%Part D≥44 patientsSensory organs
3.7%Corticosteroid3.7%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2011–2025 per NIH RePORTER. The latest:
- The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
Johns Hopkins University
FY2026$1,854,447UM1CA186691 - The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
Johns Hopkins University
FY2025$1,817,609UM1CA186691
Congress activity
Updated 27 Aug 2026
77 congress contributions (2012–2025) across AACR, ASCO per OpenAlex. The most recent:
- Abstract CT102: Exploring the tumor molecular landscape associated with<i>TMPRSS2-ERG</i>: A post hoc analysis from the phase 3 TALAPRO-2 study of first-line (1L) talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA in metastatic castration-resistant prostate cancer (mCRPC)
AACR Annual Meeting
AACR2025Co-author - Abstract LB089: Exploring androgen receptor alterations (ARa) and their potential association with efficacy of first-line (1L) talazoparib (TALA) + enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): A post hoc analysis of TALAPRO-2
AACR Annual Meeting
AACR2025Presenting authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal of clinical oncology
Guideline2026 - FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab.
Journal for immunotherapy of cancer
Clinical Trial2019
Most-cited works
by citation count (OpenAlex)- 01Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerArticle2,863 citations2015
- 02
- 03
- 04Intermittent versus Continuous Androgen Deprivation in Prostate CancerArticle573 citations2013
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/glenn-liu-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
uwhealth.org/providers/glenn-liu-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uwhealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Jefferson Medical College (Thomas Jefferson University), Philadelphia, PA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Internal Medicine Residency
University of Wisconsin Hospital and Clinics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Medical Oncology Fellowship
University of Wisconsin Hospital and Clinics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Board Certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- Chair
Prostate Cancer Subcommittee, ECOG-ACRIN Cancer Research Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Member
NCI Prostate Cancer Task Force
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Member
NCI Investigational Drug Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.wisc.edu ↗
Secondary affiliations
appointments beyond the home institution- Joint appointment
Department of Medical Physics, University of Wisconsin-Madison
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Director
Genitourinary Oncology Research Program, UW Carbone Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Natalie Callander, MD
University of Wisconsin Carbone Cancer Center
Hongtao Liu
University of Wisconsin Carbone Cancer Center
Susan Payne, MD
University of Wisconsin Carbone Cancer Center
Vaishalee Kenkre, MD
University of Wisconsin Carbone Cancer Center